Table 9.
Fatty acid composition of WSLN and CSLN
| Fatty acid | WSLN | CSLN |
|---|---|---|
| C12 | 13.06±0.03 | nd |
| C14 | 5.71±0.07 | nd |
| C16 | 7.20±0.07 | 2.44±0.13 |
| C16:1 c9 | 0.49±0.08 | 0.45±0.02 |
| C18 | 6.26±0.01 | 0.92±0.06 |
| C18:1 c9 | 30.81±0.05 | 32.21±1.46 |
| C18:1 11c | 1.31±0.02 | 1.42±0.15 |
| C22 | 2.20±0.25 | 2.96±0.09 |
| C18:4 | 1.81±0.06 | 1.98±0.10 |
| C22:5 n3 | nd | 1.07±0.03 |
| C24 | nd | 3.26±0.11 |
| μg/mg | 68.84±0.30 | 46.73±2.15 |
| SFA | 34.42±0.23 | 9.59±0.40 |
| MUFA | 32.60±0.01 | 34.09±1.62 |
| PUFA | 1.81±0.06 | 3.05±0.13 |
Note: Fatty acid composition in μg FA/mg sample ± SD.
Abbreviations: nd, not determined; c, cis double bond; t, trans double bond; SFA, total saturated fatty acids; MUFA, total monounsaturated fatty acids; PUFA, total polyunsaturated fatty acids; SD, standard deviation; CSLN, Carnauba solid lipid nanoparticles; WSLN, Witepsol solid lipid nanoparticles.